One such glycoprotein carcinoembryonic antigen (CEA) is widely used CRC molecular marker, but its association with other types of cancer (ovarian cancer, inflammatory bowel disease) has jeopardized its specificity (Yanfeng et al., 2018). This evidence concerns the gene CEACAM5 and cancer.